Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.
Full storyMedicare Drug Plan is Prescribing Profits, Business Gains Could Diminish as Program Evolves
More[Pharmacists...